N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes.
The test has been available to the public in Japan in January 2020.
What is N-NOSE?
Merit of taking a cancer screening test
The world's first biological ”diagnostic” technology.
At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.
Message from CEO
List of Officers
A paper on the latest technology for the early diagnosis and treatment of pancreatic cancer by the Joint researc . . .
With our N-NOSE® nematode cancer test, inspectors have manually performed part of the inspection process until n . . .
A book "Prime Archives in Cancer Research" was published. This book includes our joint paper with Osaka Universi . . .
N-NOSE was introduced in a web magazine "NikkeiLUXE (published by Nikkei BP)" as a new cancer test that detects . . .
A review on our collaborative study between Graduate School of Medicine of Osaka University (review on biologica . . .
Although we take the Government's state of emergency seriously, in order not to pause our first cancer screening . . .
Paper was in "International Journal of Molecular Sciences".
For more details→2020.04.20
Hirotsu Bio Science has decided to apply measures based on government policies and action plans.
We have . . .
In order to respond to the spread of the new coronavirus infection, Hirotsu Bio Science Inc. has decided to impl . . .
CEO Hirotsu's interview article was in a journal Keizaikai's "Face".
The world’s first cancer screening using biological diagnostic technology